Telix Pharmaceuticals submits NDA for Pixclara to advance brain cancer imaging

Telix Pharmaceuticals Limited (ASX: TLX) has taken a significant step in the realm of neuro-oncology by submitting a New Drug Application (NDA) to the U.S. ... Read More